Department of Neurosurgery, Fortis Memorial Research Institute, Gurgaon, India.
Department of Neurosurgery, Fortis Memorial Research Institute, Gurgaon, India.
World Neurosurg. 2018 Jun;114:117-120. doi: 10.1016/j.wneu.2018.03.019. Epub 2018 Mar 10.
Minimally invasive transportal resection of deep intracranial lesions has become a widely accepted surgical technique. Many disposable, mountable port systems are available in the market for this purpose, like the ViewSite Brain Access System. The objective of this study was to find a cost-effective substitute for these systems.
Deep-seated brain lesions were treated with a port system made from disposable syringes. The syringe port could be inserted through minicraniotomies placed and planned with navigation. All deep-seated lesions like ventricular tumours, colloid cysts, deep-seated gliomas, and basal ganglia hemorrhages were treated with this syringe port system and evaluated for safety, operative site hematomas, and blood loss.
62 patients were operated on during the study period from January 2015 to July 2017, using this innovative syringe port system for deep-seated lesions of the brain. No operative site hematoma or contusions were seen along the port entry site and tract.
Syringe port is a cost-effective and safe alternative to the costly disposable brain port systems, especially for neurosurgical setups in developing countries for minimally invasive transportal resection of deep brain lesions.
微创经通道切除颅内深部病变已成为一种广泛接受的手术技术。为此，市场上有许多可重复使用、可安装的端口系统，如 ViewSite Brain Access System。本研究的目的是寻找这些系统的经济有效的替代品。
采用一次性注射器制成的端口系统治疗深部脑病变。可以通过导航放置和计划的微型开颅术插入注射器端口。所有深部病变，如脑室肿瘤、胶样囊肿、深部胶质瘤和基底节出血，均采用该注射器端口系统进行治疗，并评估其安全性、手术部位血肿和出血量。
2015 年 1 月至 2017 年 7 月期间，62 例患者采用该创新的注射器端口系统治疗脑深部病变。在端口入口部位和通道沿线未观察到手术部位血肿或挫伤。
注射器端口是一种具有成本效益的、安全的替代品，可替代昂贵的一次性脑端口系统，特别是对于发展中国家的神经外科微创经通道切除深部脑病变的设备。
